Human herpesvirus-6 and-7 in transplantation

Reviews in Medical Virology

Volumn 11, Issue 1, 2001, Pages 23-36

  Dockrell, David H ^a   Paya, Carlos V ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; DIAGNOSTIC TEST; ENCEPHALITIS; FEVER; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PNEUMONIA; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TITRATION;

BONE MARROW DISEASES; CULTURE TECHNIQUES; ENCEPHALITIS; FEVER; HEPATITIS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; PNEUMONIA; POLYMERASE CHAIN REACTION; SEROLOGY; TRANSPLANTATION;

EID: 0035147492     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.299     Document Type: Review

References (110)

1. The future of transplantation: With particular reference to chimerism and xenotransplantation
2. Infections in solid-organ transplant recipients
3. Cytomegalovirus infection in organ transplant recipients
4. Cytomegalovirus infection following liver transplantation: Review of the literature
5. Human herpesviruses at sixes, sevens, and more
6. High prevalence of antibody to human herpesvirus-6 seroconversion associated with rash in two infants
7. Human herpesvirus 7: Antigenic properties and prevalence in children and adults
8. Human herpesvirus 6
9. Human herpesvirus 7
10. Human herpesvirus 6 in AIDS
11. Human herpesvirus-6 in transplantation: An emerging pathogen
12. New discovered human herpesvirus (HHV-6 and HHV-7)
13. Three new human herpesviruses (HHV6, 7, and 8)
14. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
15. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6
16. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates
17. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction
18. Isolation of a new herpesvirus from human CD4+ T cells
19. Human herpesvirus 6 and human herpesvirus 7 infection: The viruses and their disease manifestations
20. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus
21. Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus
22. Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: Substitution of human cytomegalovirus glycoproteins permits group-specific complex formation
23. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution
24. Human herpesvirus 6B genome sequence: Coding content and comparison with human herpesvirus 6A
25. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B
26. Preferential associations of alleles of three distinct genes argue for the existence of two prototype variants of human herpesvirus 7
27. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6
28. In vitro activation of human herpesviruses 6 and 7 from latency
29. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture
30. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53
31. Replication of human herpesvirus 6 in epithelial cells in vitro
32. CD46 is a cellular receptor for human herpesvirus 6
33. Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen
34. Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6
35. Persistence of human herpesvirus 6 according to site and variant: Possible greater neurotropism of variant A
36. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo
37. Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures
38. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells
39. Identification of human herpesvirus-6 as a causal agent for exanthem subitum
40. Human herpesvirus 6
41. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies
42. Dual antibody rises to cytomegalovirus and human herpesvirus type 6: Frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses
43. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus
44. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: Suppression of interleukin-2 synthesis and cell proliferation
45. Induction of T-cell apoptosis by human herpesvirus 6
46. Human herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: Necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells
47. In vitro cytobiological effects of human herpesviruses 6 and 7: Immunohistological monitoring of apoptosis, differentiation and cell proliferation
48. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice
49. Infection of natural killer cells by human herpesvirus 6
50. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15
51. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction
52. Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes
53. Human herpesvirus 6 infection increases adhesion molecule expression in liver allografts
54. Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor
55. Human herpesvirus 6 open reading frame U83 encodes a functional chemokine
56. Human herpesvirus 6 infection in renal-transplant recipients
57. Human herpesvirus-6 infection and renal transplantation
58. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease
59. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection
60. Human herpesvirus-6 and bone marrow transplantation
61. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction
62. Quantitative PCR for human herpesviruses 6 and 7
63. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction
64. A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products
65. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppresive role for HHV-6 in vivo
66. Human herpesvirus-6 infection in bone marrow transplantation
67. Human herpesvirus 6: Infection and disease following autologous and allogeneic bone marrow transplantation
68. Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne bone marrow transport group
69. Lymphotropic herpesviruses in allogeneic bone marrow transplantation
70. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients
71. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
72. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6
73. Herpesvirus type 6 in patients undergoing bone marrow transplantation: Serologic features and detection by polymerase chain reaction
74. Human herpes virus 6 infections in hospitalized renal transplant recipients
75. Human herpesvirus 6 infection in renal transplantation
76. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection
77. A prospective study of human herpesvirus-6 infection in renal transplantation
78. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients
79. Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients
80. Prospective study of human betaherpesviruses after renal transplantation
81. Human herpesvirus-6 infection after liver transplantation
82. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation
83. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus
84. Human herpesvirus-6 infection and hepatitis following heart transplantation
85. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method
86. Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion
87. Brief report: Primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor
88. Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation
89. Fever in liver transplant recipients: Changing spectrum of etiologic agents
90. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient
91. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation
92. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation
93. Coinfection with human herpesvirus 6 variants A and B in lung tissue
94. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity
95. Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium
96. Brief report: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient
97. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient
98. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant
99. Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy?
100. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it have clinical significance?
101. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients
102. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient
103. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection
104. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6
105. Cytomegalovirus disease in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?
106. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients
107. Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy
108. Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection
109. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6
110. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients